Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.9000
+0.0020 (0.22%)
Sep 11, 2026, 12:17 PM CET
Stenocare Revenue
Stenocare had revenue of 4.00M DKK in the quarter ending June 30, 2026, with 132.55% growth. This brings the company's revenue in the last twelve months to 11.52M, up 306.70% year-over-year. In the year 2025, Stenocare had annual revenue of 7.02M with 214.56% growth.
Revenue (ttm)
11.52M
Revenue Growth
+306.70%
P/S Ratio
3.37
Revenue / Employee
2.88M
Employees
4
Market Cap
38.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.02M | 4.79M | 214.56% |
| Dec 31, 2024 | 2.23M | -1.53M | -40.61% |
| Dec 31, 2023 | 3.76M | -731.58K | -16.30% |
| Dec 31, 2022 | 4.49M | 2.60M | 137.54% |
| Dec 31, 2021 | 1.89M | 1.69M | 852.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 329.43B |
| Coloplast | 28.44B |
| Genmab | 27.03B |
| Demant | 24.63B |
| Gubra | 271.02M |
| Scandinavian Medical Solutions | 214.99M |
| BioPorto | 38.37M |
| ViroGates | 9.36M |
Stenocare News
- 22 days ago - Stenocare Quarterly report: Q2 2026 - Filings
- 4 months ago - Stenocare Quarterly report: Q1 2026 - Filings
- 6 months ago - Stenocare Quarterly report: Q4 2025 - Filings
- 10 months ago - Stenocare Quarterly report: Q3 2025 - Filings